We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D-Printed Bandage to Help Heal Chronic Wounds

By HospiMedica International staff writers
Posted on 05 Mar 2026

Chronic wounds such as diabetic ulcers and pressure sores can persist for months or even years, especially in people with diabetes or limited mobility. More...

These wounds often receive poor oxygen supply, slowing the body’s natural healing process and increasing the risk of infection. Traditional dressings may not always provide the specialized support needed for these difficult-to-heal injuries. Researchers are now exploring a new approach using customizable 3D-printed medicated patches designed to support tissue repair and prevent infection.

Scientists at the University of Mississippi (Oxford, MS, USA) have developed a breathable wound scaffold that can be produced using 3D printing technology and tailored to match the size and shape of a patient’s wound. The patch is made from chitosan, a biodegradable material derived from crustaceans, insects, and fungi. Chitosan is combined with plant-derived antimicrobial compounds that help protect wounds from infection while supporting the growth of new skin cells.

The 3D-printed scaffold functions as both a protective barrier and a structural support for tissue repair. It gradually releases natural antibacterial agents that help prevent microbial growth without relying on conventional antibiotics. Unlike many wound dressings that are produced using organic solvents, the new scaffold avoids chemicals that may hinder healing. The material, highlighted in the European Journal of Pharmaceutics and Biopharmaceutics, is also biodegradable, meaning it can gradually dissolve as the wound heals, eliminating the need for surgical removal.

Because the scaffold is produced using a 3D printer, it can be customized to fit wounds on different parts of the body. Researchers suggest the technology could also be useful in situations where traditional bandages are not practical, including battlefield or emergency medical settings where on-demand wound treatment is needed. Before the technology can be used clinically, further testing and regulatory review will be required to evaluate its safety and effectiveness.

"Depending on what kind of wound it is, a regular bandage might work well and this wouldn't be necessary," said Michael Repka, distinguished professor of pharmaceutics and drug delivery. "But there are a lot of applications for this technology. If you have a generator that can run these 3D printers, you can print the scaffold you need based on what kind of wound has occurred."

Related Links:
University of Mississippi


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.